Literature DB >> 29879879

Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing.

Predrag Sikiric1, Rudolf Rucman1, Branko Turkovic1, Marko Sever1, Robert Klicek1, Bozo Radic1, Domagoj Drmic1, Mirjana Stupnisek1, Marija Misic1, Lovorka Batelja Vuletic1, Katarina Horvat Pavlov1, Ivan Barisic1, Antonio Kokot1, Marina Peklic1, Sanja Strbe1, Alenka Boban Blagaic1, Ante Tvrdeic1, Dinko Stancic Rokotov1, Hrvoje Vrcic1, Mario Staresinic1, Sven Seiwerth1.   

Abstract

Years ago, we revealed a novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157, particular anti-ulcer peptide that heals different organs lesions when given as a therapy, native in human gastric juice while maintaining GI-tract mucosal integrity, already tested in trials (ulcerative colitis and now multiple sclerosis). The stomach cytoprotection is the most fundamental concept, stomach cell protection and endothelium protection are largely elaborated, but so far cell, protection and endothelium protection outside of the stomach were not implemented in the therapy. However, having managed these two points, stomach cell protection and endothelium protection, either one or together, even much more than standard cytoprotective agents do, BPC 157 employed large scale of its beneficial effects seen in various organs. Providing endothelium protection, BPC 157 was shown to prevent formation and reverse established thrombosis in anastomosed abdominal aorta as well as venous thrombosis after inferior caval vein occlusion, and attenuate bleeding prolongation and thrombocytopenia after amputation, without or with anticoagulants, or venous occlusion, and finally counteract effect of L-NAME and/or L- arginine. Now, with BPC 157 application, we reveal the third most important part of the cytoprotection concept: with the stomach cell and endothelium protection to recover mucosal integrity, BPC 157 as prototype cytoprotective agent should also control blood vessel function, depending upon injury, perforated defect or vessel obstruction. After a perforated injury (i.e., stomach), BPC 157 therapy activates blood vessels "running" towards defect. After obstruction (i.e., inferior caval vein), BPC 157 activates vessels "running" towards bypassing defect, collaterals functioning. Reestablished blood flow, and largely reversed injurious course may practically implement the cytoprotection concept. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Stable gastric pentadecapeptide BPC 157; control of blood vessels function; cytoprotection; endothelium protection; organoprotection; stomach cells protection.

Mesh:

Substances:

Year:  2018        PMID: 29879879     DOI: 10.2174/1381612824666180608101119

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

1.  Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats.

Authors:  Ivan Maria Smoday; Igor Petrovic; Luka Kalogjera; Hrvoje Vranes; Helena Zizek; Ivan Krezic; Slaven Gojkovic; Ivan Skorak; Klaudija Hriberski; Ivan Brizic; Milovan Kubat; Sanja Strbe; Ivan Barisic; Marija Sola; Eva Lovric; Marin Lozic; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2022-06-01

2.  Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy.

Authors:  Darko Perovic; Marija Milavic; Stjepan Dokuzovic; Ivan Krezic; Slaven Gojkovic; Hrvoje Vranes; Igor Bebek; Vide Bilic; Nenad Somun; Ivan Brizic; Ivan Skorak; Klaudija Hriberski; Suncana Sikiric; Eva Lovric; Sanja Strbe; Milovan Kubat; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Curr Issues Mol Biol       Date:  2022-04-27       Impact factor: 2.976

3.  Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion.

Authors:  Marijan Kolovrat; Slaven Gojkovic; Ivan Krezic; Dominik Malekinusic; Borna Vrdoljak; Katarina Kasnik Kovac; Tamara Kralj; Domagoj Drmic; Ivan Barisic; Katarina Horvat Pavlov; Andreja Petrovic; Antonija Duzel; Mario Knezevic; Ivan Mirkovic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth; Predrag Sikiric
Journal:  World J Hepatol       Date:  2020-05-27

Review 4.  Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future.

Authors:  Predrag Sikiric; Ki-Baik Hahm; Alenka Boban Blagaic; Ante Tvrdeic; Katarina Horvat Pavlov; Andrea Petrovic; Antonio Kokot; Slaven Gojkovic; Ivan Krezic; Domagoj Drmic; Rudolf Rucman; Sven Seiwerth
Journal:  Gut Liver       Date:  2020-03-15       Impact factor: 4.519

Review 5.  Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

Authors:  Sven Seiwerth; Marija Milavic; Jaksa Vukojevic; Slaven Gojkovic; Ivan Krezic; Lovorka Batelja Vuletic; Katarina Horvat Pavlov; Andrea Petrovic; Suncana Sikiric; Hrvoje Vranes; Andreja Prtoric; Helena Zizek; Tajana Durasin; Ivan Dobric; Mario Staresinic; Sanja Strbe; Mario Knezevic; Marija Sola; Antonio Kokot; Marko Sever; Eva Lovric; Anita Skrtic; Alenka Boban Blagaic; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

6.  BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats.

Authors:  Mirna Zlatar; Antonio Kokot; Lovorka Batelja Vuletic; Sanja Masnec; Tamara Kralj; Marija Milkovic Perisa; Ivan Barisic; Bozo Radic; Kristina Milanovic; Domagoj Drmic; Sven Seiwerth; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

7.  Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats.

Authors:  Ivan Mirković; Tamara Kralj; Marin Lozić; Vasilije Stambolija; Josip Kovačević; Luka Vrdoljak; Mirna Zlatar; Kristina Milanović; Domagoj Drmić; Jurica Predović; Sanja Masnec; Matija Jurjević; Mladen Bušić; Sven Seiwerth; Antonio Kokot; Predrag Sikirić
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

8.  Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension.

Authors:  Mario Knezevic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Dominik Malekinusic; Borna Vrdoljak; Hrvoje Vranes; Tamara Knezevic; Ivan Barisic; Katarina Horvat Pavlov; Domagoj Drmic; Miro Staroveski; Antonija Djuzel; Zoran Rajkovic; Toni Kolak; Ivica Kocman; Eva Lovric; Marija Milavic; Suncana Sikiric; Ante Tvrdeic; Leonardo Patrlj; Sanja Strbe; Antonio Kokot; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2021-05-26

9.  Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats.

Authors:  Slaven Gojkovic; Ivan Krezic; Borna Vrdoljak; Dominik Malekinusic; Ivan Barisic; Andreja Petrovic; Katarina Horvat Pavlov; Marijan Kolovrat; Antonija Duzel; Mario Knezevic; Katarina Kasnik Kovac; Domagoj Drmic; Lovorka Batelja Vuletic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth; Predrag Sikiric
Journal:  World J Gastrointest Pathophysiol       Date:  2020-03-13

10.  Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot.

Authors:  Sanja Konosic; Mate Petricevic; Visnja Ivancan; Lucija Konosic; Eleonora Goluza; Branimir Krtalic; Domagoj Drmic; Mirjana Stupnisek; Sven Seiwerth; Predrag Sikiric
Journal:  Oxid Med Cell Longev       Date:  2019-12-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.